Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,174 across all filing types
Latest filing 2025-01-08 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Lupin Receives EIR from U. S. FDA for its Pithampur Unit-1 Facility with VAI Classification.
Regulatory Filings Classification · 95% confidence The document is a press release announcing the receipt of an Establishment Inspection Report (EIR) from the U.S. FDA for Lupin Limited's manufacturing facility. It is a short communication primarily for information dissemination and does not contain detailed financial data, audit results, or regulatory filings. It is not a full report but an announcement of a regulatory event. The document length is 4094 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-01-08 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the receipt of an Establishment Inspection Report (EIR) from the U.S. FDA for Lupin Limited's manufacturing facility. It is a short document (4094 characters) and does not contain any detailed financial data, audit results, or comprehensive report content. It is an announcement of a regulatory inspection outcome rather than the report itself. The document is intended for public dissemination and regulatory compliance under SEBI Listing Regulations. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-01-08 English
Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2018.
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming dematerialisation activities for the quarter ended December 31, 2024. It is a compliance certificate issued by the Registrar and Share Transfer Agent to the stock exchanges and the company. The document is short (3414 characters) and primarily serves as a regulatory compliance confirmation rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is not an announcement of voting results, nor a report on board changes or legal proceedings. It fits best under Regulatory Filings (RNS) as a compliance certificate under SEBI regulations.
2025-01-06 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialisation of securities for the quarter ended December 31, 2024. It is a compliance certificate issued by the Registrar and Share Transfer Agent to the company and stock exchanges. The document is short (3414 characters) and primarily serves as a regulatory compliance confirmation rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is not an announcement of a report but a certificate confirming regulatory compliance. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and miscellaneous regulatory documents.
2025-01-06 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges about a change in the name of the company's Registrar and Share Transfer Agent (RTA). It includes a certificate of incorporation pursuant to the change of name issued by the Ministry of Corporate Affairs. The content is administrative and regulatory in nature, focusing on a name change and related certification, without any financial data, management discussion, or report publication. The document length is under 5,000 characters and serves as an official announcement rather than a detailed report or financial filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-01-02 English
Intimation regarding change in name of Registrar and Share Transfer Agent of the Company.
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges about a change in the name of the company's Registrar and Share Transfer Agent (RTA). It includes a certificate of incorporation pursuant to the change of name issued by the Ministry of Corporate Affairs, Government of India. The document is short (under 5,000 characters) and primarily serves as an official announcement of a corporate administrative change rather than a financial report or detailed filing. There are no financial statements, management discussions, or regulatory certifications beyond the name change certificate. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other specific categories.
2025-01-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.